Recall Enforment Report D-0077-2018

Recall Details

Multi event Drug Recall Enforcement Report Class III voluntary initiated by Allergan Sales, LLC, originally initiated on 10-19-2017 for the product Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023-9211-03; b) 5 mL (NDC# 0023-9211-05); c) 10 mL (NDC# 0023-9211-10); d) 15 mL (NDC# 0023-9211-15) bottles, Manufactured By: Allergan, Irvine, CA 92612.. The product was recalled due to failed impurities/degradation specifications.. The product was distributed nationwide and the recall is currently terminated.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0077-201810-19-201711-22-2017Class III715,041 bottlesCombigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023-9211-03; b) 5 mL (NDC# 0023-9211-05); c) 10 mL (NDC# 0023-9211-10); d) 15 mL (NDC# 0023-9211-15) bottles, Manufactured By: Allergan, Irvine, CA 92612..Failed Impurities/Degradation Specifications.Terminated
D-0078-201810-19-201711-22-2017Class III153,616 bottlesLumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612. NDC# 0023-3205-03Failed Impurities/Degradation Specifications.Terminated

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0023-3205Lumigan BimatoprostSolution/ DropsOphthalmicAllergan, Inc.Human Prescription Drug
0023-9211Combigan Brimonidine Tartrate, Timolol MaleateSolution/ DropsOphthalmicAllergan, Inc.Human Prescription Drug